Monmouth Junction, NJ, USA, 4th December 2001— MicroDose Technologies Inc. ( MicroDose ), a leading drug delivery company, announced today the successful completion of a Phase I clinical study evaluating the pulmonary delivery of human insulin, being conducted with joint venture partner, Elan Corporation, plc ( Elan ).